Clinical Trial Update: The Immunomodulatory Effect of Sugammadex After Total Hip Replacement Surgery Under Neuraxial Anaesthesia: a Pilot Study [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating the immunomodulatory effect of sugammadex after total hip replacement under neuraxial anesthesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Innate Inflammatory Response
• Osteoarthritis Hip

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Innate Inflammatory Response, Osteoarthritis, Hip | Phase 2 | Status: COMPLETED